BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 18226657)

  • 1. Chronic pain in persons with myotonic dystrophy and facioscapulohumeral dystrophy.
    Jensen MP; Hoffman AJ; Stoelb BL; Abresch RT; Carter GT; McDonald CM
    Arch Phys Med Rehabil; 2008 Feb; 89(2):320-8. PubMed ID: 18226657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in pain-related beliefs, coping, and catastrophizing predict changes in pain intensity, pain interference, and psychological functioning in individuals with myotonic muscular dystrophy and facioscapulohumeral dystrophy.
    Nieto R; Raichle KA; Jensen MP; Miró J
    Clin J Pain; 2012 Jan; 28(1):47-54. PubMed ID: 21642844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of biopsychosocial factors on chronic pain in persons with myotonic and facioscapulohumeral muscular dystrophy.
    Miró J; Raichle KA; Carter GT; O'Brien SA; Abresch RT; McDonald CM; Jensen MP
    Am J Hosp Palliat Care; 2009; 26(4):308-19. PubMed ID: 19414560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pain location and intensity impacts function in persons with myotonic dystrophy type 1 and facioscapulohumeral dystrophy with chronic pain.
    Miró J; Gertz KJ; Carter GT; Jensen MP
    Muscle Nerve; 2014 Jun; 49(6):900-5. PubMed ID: 24415580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatric disorders appear equally in patients with myotonic dystrophy, facioscapulohumeral dystrophy, and hereditary motor and sensory neuropathy type I.
    Kalkman JS; Schillings ML; Zwarts MJ; van Engelen BG; Bleijenberg G
    Acta Neurol Scand; 2007 Apr; 115(4):265-70. PubMed ID: 17376125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy.
    Fitzgerald BP; Conn KM; Smith J; Walker A; Parkhill AL; Hilbert JE; Luebbe EA; Moxley RT
    J Neurol; 2016 Dec; 263(12):2528-2537. PubMed ID: 27734165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptom burden in persons with myotonic and facioscapulohumeral muscular dystrophy.
    Smith AE; McMullen K; Jensen MP; Carter GT; Molton IR
    Am J Phys Med Rehabil; 2014 May; 93(5):387-95. PubMed ID: 24247759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic pain has a strong impact on quality of life in facioscapulohumeral muscular dystrophy.
    Morís G; Wood L; FernáNdez-Torrón R; González Coraspe JA; Turner C; Hilton-Jones D; Norwood F; Willis T; Parton M; Rogers M; Hammans S; Roberts M; Househam E; Williams M; Lochmüller H; Evangelista T
    Muscle Nerve; 2018 Mar; 57(3):380-387. PubMed ID: 29053898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life and pain in patients with facioscapulohumeral muscular dystrophy.
    Padua L; Aprile I; Frusciante R; Iannaccone E; Rossi M; Renna R; Messina S; Frasca G; Ricci E
    Muscle Nerve; 2009 Aug; 40(2):200-5. PubMed ID: 19609906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-Reported Symptoms in Facioscapulohumeral Muscular Dystrophy (PRISM-FSHD).
    Hamel J; Johnson N; Tawil R; Martens WB; Dilek N; McDermott MP; Heatwole C
    Neurology; 2019 Sep; 93(12):e1180-e1192. PubMed ID: 31409737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experiences with bariatric surgery in patients with facioscapulohumeral dystrophy and myotonic dystrophy type 1: A qualitative study.
    Abel EEDH; Cup EHC; Lanser A; Leclercq WKG; Raaphorst J; Padberg GW; Satink T; Voermans NC
    Neuromuscul Disord; 2018 Nov; 28(11):938-946. PubMed ID: 30342904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The facioscapulohumeral muscular dystrophy - health index: Italian validation of a disease-specific measure of symptomatic burden.
    Carraro E; Greco LC; Lizio A; Beretta M; Pozzi S; Casiraghi J; Becchiati S; Beshiri F; Frisoni MC; Iossa F; Heatwole C; Sansone V
    Disabil Rehabil; 2024 May; 46(10):2130-2137. PubMed ID: 37194629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of a model of fatigue in neuromuscular disorders: a longitudinal study.
    Kalkman JS; Schillings ML; Zwarts MJ; van Engelen BG; Bleijenberg G
    J Psychosom Res; 2007 May; 62(5):571-9. PubMed ID: 17467412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic pain in persons with neuromuscular disease.
    Jensen MP; Abresch RT; Carter GT; McDonald CM
    Arch Phys Med Rehabil; 2005 Jun; 86(6):1155-63. PubMed ID: 15954054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upper limb function and activity in people with facioscapulohumeral muscular dystrophy: a web-based survey.
    Bergsma A; Cup EH; Janssen MM; Geurts AC; de Groot IJ
    Disabil Rehabil; 2017 Feb; 39(3):236-243. PubMed ID: 26942834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pain and the alpha-sleep anomaly: a mechanism of sleep disruption in facioscapulohumeral muscular dystrophy.
    Della Marca G; Frusciante R; Vollono C; Iannaccone E; Dittoni S; Losurdo A; Testani E; Gnoni V; Colicchio S; Di Blasi C; Erra C; Mazza S; Ricci E
    Pain Med; 2013 Apr; 14(4):487-97. PubMed ID: 23387524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. If you build a rare disease registry, will they enroll and will they use it? Methods and data from the National Registry of Myotonic Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSHD).
    Hilbert JE; Kissel JT; Luebbe EA; Martens WB; McDermott MP; Sanders DB; Tawil R; Thornton CA; Moxley RT;
    Contemp Clin Trials; 2012 Mar; 33(2):302-11. PubMed ID: 22155025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal and genitourinary symptoms in facioscapulohumeral muscular dystrophy: Prevalence and impact.
    Cole MR; Cooper CS; Hanna EM; Zimmerman MB; Kinoshita J; Mathews KD
    Muscle Nerve; 2024 Mar; 69(3):325-333. PubMed ID: 38158588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and correlates of apathy in myotonic dystrophy type 1.
    Gallais B; Montreuil M; Gargiulo M; Eymard B; Gagnon C; Laberge L
    BMC Neurol; 2015 Aug; 15():148. PubMed ID: 26296336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facing facial weakness: psychosocial outcomes of facial weakness and reduced facial function in facioscapulohumeral muscular dystrophy.
    van de Geest-Buit WA; Rasing NB; Mul K; Deenen JCW; Vincenten SCC; Siemann I; Lanser A; Groothuis JT; van Engelen BG; Custers JAE; Voermans NC
    Disabil Rehabil; 2023 Jul; 45(15):2507-2516. PubMed ID: 35815498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.